Search
for
Sort by
Research 901–930 of 1000+
- Recent advances in natural hydrolates for burn care: Anti-inflammatory, antioxidant and antimicrobial perspectives
- Cell death as an architect of adult skin stem cell niches
- Taurine, a non-proteinous essential amino acid for human body systems: an overview
- Nanotechnological Interventions and Mechanistic Insights into Wound-Healing Events
- Atopic diseases and the risk of alopecia areata among pre-teens and teenagers in Taiwan
- Intralesional methotrexate in patchy alopecia areata: trichoscopic evaluation and effect on lesional tumour necrosis factor alpha
- Platelet-rich plasma as a potential treatment for noncicatricial alopecias
- Advanced 3D/4D Bioprinting of Flexible Conductive Materials for Regenerative Medicine: From Bioinspired Design to Intelligent Regeneration
- Polycystic Ovary Syndrome and Eating Disorders—A Literature Review
- Melatonin Modulates Tomato Root Morphology by Regulating Key Genes and Endogenous Hormones
- Corticosterone enhances the potency of ethanol against hippocampal long-term potentiation via local neurosteroid synthesis
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Inhibiting Janus kinases to treat alopecia areata
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Baricitinib for alopecia areata
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- Janus kinase inhibitors for alopecia areata
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Treatment of severe alopecia areata with baricitinib
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Evidence for the off-label use of tofacitinib in alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study